Clinical Edge Journal Scan

Protective action of impaired fasting glucose on osteoporosis risk


 

Key clinical point: Patients with impaired fasting glucose (IFG) and diabetes mellitus (DM) have a lower risk for incident osteoporosis.

Major finding: The risk of osteoporosis significantly decreased ( P less than .001 for all) above the fourth quartile of fasting glucose levels in men and above the third quartile in women compared with the first quartile. The risk of osteoporosis was significantly lower ( P less than .001 for all) with IFG (men: hazard ratio [HR], 0.84; women: HR, 0.93) and DM (men: HR, 0.77; women: HR, 0.75) compared with the normal glucose group.

Study details: The data come from a retrospective study of 96,626 patients.

Disclosures: No study sponsor was identified. The authors declared no conflicts of interest.

Source: Park SK et al. Bone. 2020 Oct 21. doi: 10.1016/j.bone.2020.115690 .

Recommended Reading

Lung cancer CT scan is chance for ‘opportunistic’ osteoporosis check
MDedge Rheumatology
To D or not to D? Vitamin D doesn’t reduce falls in older adults
MDedge Rheumatology
Oral steroids plus PPIs increase osteoporotic fracture risk in RA patients
MDedge Rheumatology
Teenage bone density declines following sleeve gastrectomy
MDedge Rheumatology
Zoledronic acid treatment for osteoporosis modestly raises AFib risk
MDedge Rheumatology
BMD and bone turnover after gastric bypass vs. sleeve gastrectomy
MDedge Rheumatology
Corticosteroids for asthma could raise osteoporosis and fragility fracture risk
MDedge Rheumatology
Denosumab not linked to malignancy risk in patients with osteoporosis
MDedge Rheumatology
Efficacy of romosozumab followed by denosumab in women at high risk of fracture
MDedge Rheumatology
Psoriasis tied to increased risk for osteoporosis
MDedge Rheumatology